(Q60035740)

English

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification

scientific article published on 01 March 2001

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification (English)

0 references

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

Jo Vandesompele

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Olivier Delattre

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

D. Plantaz

1

0 references

J. Vandesompele

2

0 references

N. Van Roy

3

0 references

M. Łastowska

4

0 references

N. Bown

5

0 references

V. Combaret

6

0 references

M.C. Favrot

7

0 references

O. Delattre

8

0 references

J. Michon

9

0 references

J. Bénard

10

0 references

O. Hartmann

11

0 references

J.C. Nicholson

12

0 references

F.M. Ross

13

0 references

C. Brinkschmidt

14

0 references

G. Laureys

15

0 references

H. Caron

16

0 references

K.K. Matthay

17

0 references

B.G. Feuerstein

18

0 references

F. Speleman

19

0 references

D Plantaz

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

N Van Roy

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Lastowska

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

N Bown

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V Combaret

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M C Favrot

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Michon

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Bénard

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

O Hartmann

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J C Nicholson

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F M Ross

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Brinkschmidt

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Laureys

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Caron

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K K Matthay

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B G Feuerstein

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Speleman

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

2001

0 references

1 March 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

International Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

91

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

680-686

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Molecular biology and genetics of human neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Deletion of chromosome 11 and of 14q sequences in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Neuroblastoma in a boy with MCA/MR syndrome, deletion 11q, and duplication 12q.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1114%3E3.0.CO%3B2-R

21 January 2018

Identifiers

10.1002/1097-0215(200002)9999:9999<::AID-IJC1114>3.0.CO;2-R

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267980%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60035740&oldid=2134609956"